The Egyptian Drug Authority has issued a warning against 19 unlicensed advertisements for products registered with the authority. These advertisements violate the controls and rules regulating the promotion and advertising of products and preparations. The authority emphasized that some advertisements contain misleading marketing claims that may affect citizens' decisions to use products and potentially lead to misuse and health risks.
The authority's monitoring of these violations is part of its regulatory and regulatory role, within the framework of periodic monitoring and follow-up procedures. The authority's central department for pharmaceutical care and the general department for regulating marketing and advertising materials are involved in this process. The authority also receives reports from citizens, which helps in identifying and addressing these violations.
The Egyptian Drug Authority stressed that the registration of a product with the authority does not automatically permit its promotion or advertising. Any advertisement must obtain the necessary license in accordance with the regulating controls. The authority noted that some violating advertisements included misleading marketing claims that could affect citizens' decisions and lead to product misuse.
The authority clarified its stance on violating advertisements, stating that including a product or advertisement in lists of advertising violations reflects its regulatory and supervisory position based on proven facts at the time of publication. The authority emphasized that this inclusion does not represent a judicial ruling but rather part of the regulatory procedures it takes against violations.
The Egyptian Drug Authority warned citizens against following unidentified advertisements or unverified information, especially those containing marketing claims or unapproved product information. The authority called on citizens to verify information before purchasing or using any product and to refer to official sources for accurate information.
The authority urged citizens to participate in monitoring and reporting violating advertisements through available channels. Reports can be submitted via the Egyptian Drug Authority's hotline at 15301, through the designated electronic link for receiving reports, or by using the QR Code available for this service.
The Egyptian Drug Authority's warning aims to protect public health by ensuring that advertisements for registered products comply with regulatory requirements. The authority remains committed to monitoring and addressing violations to prevent potential health risks associated with misleading or unlicensed advertisements.
Key points
- The Egyptian Drug Authority has warned against 19 unlicensed advertisements for registered products.
- The authority emphasized that registration of a product does not automatically permit its promotion or advertising.
- Citizens are urged to verify information and report violating advertisements through available channels.
